Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients - Drug Trials For Money - Paid Clinical Trials

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
Condition:   Advanced Ovarian Cancer
Interventions:   Drug: Bevacizumab;   Drug: Durvalumab;   Drug: Olaparib;   Drug: Placebo olaparib;   Drug: Durvalumab placebo;   Drug: Carboplatin+Paclitaxel
Sponsors:   AstraZeneca;   European Network of Gynaecological Oncological Trial Groups (ENGOT);   GOG Foundation, Inc. (GOG Foundation);   Myriad Genetic Laboratories, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 7, 2022 / by / in
Comments